PATENT PENDING

US #18/467,595

PATENT PENDING

US #18/467,595

ALL RIGHTS RESERVED | 2024 RIBODEX LLC

ALL RIGHTS RESERVED | 2024 RIBODEX LLC

Programmed Ribosomes

for Protein Synthesis

Programmed Ribosomes

for Protein Synthesis

Next-Level Cell Therapeutics and Rejuvenation

Next-Level Cell Therapeutics and Rejuvenation

QUANTUM SCIENCE

IN CELL THERAPY EVOLUTION

A groundbreaking advancement
in quantum science impacting cell therapy.

A groundbreaking advancement
in quantum science impacting cell therapy.

Potential to be one of the leading cell therapy approaches.

What are Ribosomes?

What are Ribosomes?

Ribosomes synthesize all essential proteins required for the proper functioning and maintenance of the human body.

mRNA Translation Process

mRNA Translation Process

Animation

Animation

RIBOSOMES read messenger RNA (mRNA) sequences and translate them into polypeptide chains, which then fold into functional proteins essential for various cellular activities.

Evolution in Cell Therapy

RIBODEX’s proprietary quantum-powered ribosomal

programming method allows protein synthesis with limited presence of messenger RNA (mRNA) -making them immune-friendly.

RIBODEX’s proprietary quantum-powered ribosomal

programming method allows protein synthesis with limited presence of messenger RNA (mRNA) -making them immune-friendly.

Ribosomal
Programming
Process

Ribosomal
Programming
Process

EVOLUTIONARY ADVANCEMENT

IN CELL THERAPY

RIBOSOME PROGRAMMING represents an
Potential to be one of the leading cell therapy approaches:
Such as stem cells, Platelet-Rich Plasma (PRP), and exosome therapies.

RIBOSOME PROGRAMMING represents an
Potential to be one of the leading cell therapy approaches:
Such as stem cells, Platelet-Rich Plasma (PRP), and exosome therapies.

Advanced therapeutic efficacy and minimum risk

Programmed Ribosome.

The next evolution step in Cell Therepy

The next evolution step in Cell Therepy

Targeted Action: Designed to produce specific proteins for therapeutic purposes.

Targeted Action: Designed to produce specific proteins for therapeutic purposes.

Enhanced Efficacy: Stem cells typically achieve approx. 10% delivery efficiency and often differentiate unpredictably.
In contrast, ribosome-based therapy is pre-programmed to produce all the necessary proteins, enabling precise
and controlled therapeutic outcomes.

Enhanced Efficacy: Stem cells typically achieve approx. 10% delivery efficiency and often differentiate unpredictably.
In contrast, ribosome-based therapy is pre-programmed to produce all the necessary proteins, enabling precise
and controlled therapeutic outcomes.

No Negative Immune Response: The segregation of messenger RNA (mRNA) minimizes the risk of triggering
immune rejection, ensuring safer therapeutic applications.

No Negative Immune Response: The segregation of messenger RNA (mRNA) minimizes the risk of triggering
immune rejection, ensuring safer therapeutic applications.

No Observed Side Effects: As ribosomal treatments could be more targeted, they potentially have fewer or no side effects.

No Observed Side Effects: As ribosomal treatments could be more targeted, they potentially have fewer or no side effects.

Fewer Ethical Concerns: programmed ribosomal treatments pose no ethical concerns.

Fewer Ethical Concerns: programmed ribosomal treatments pose no ethical concerns.

Integration into clinical settings

Integration into clinical settings

The application methodologies for ribosomal therapies maintain a synergy with historically established protocols in the administration of stem cells, PRP, and exosomes, ensuring a seamless integration into the current therapeutic applications.

Customized Applications

Preprogrammed ribosomes are used to create targeted FGF-7 and VEGF proteins, which are crucial for hair follicle stimulation and growth.

Preprogrammed ribosomes are used to create targeted FGF-7 and VEGF proteins, which are crucial for hair follicle stimulation and growth.

Introducing RiboHair™

Hair Growth Technology

RiboHair targets hair loss by supporting the natural hair
growth cycle and creating a healthy scalp environment that
promotes hair regeneration.

Introducing RiboHair™

Introducing RiboHair™

Hair Growth Technology

The mechanism behind RiboHair™ involves ribosomes

programmed to produce specific proteins and growth factors, notably FGF-7 and VEGF, which are crucial for hair follicle stimulation and growth.

These bioactive molecules extend the hair's growth phase and encourage the activation of hair follicles, offering a potent solution to combat hair thinning and loss, and promoting denser, healthier hair growth.

The mechanism behind RiboHair™ involves ribosomes

programmed to produce specific proteins and growth factors, notably FGF-7 and VEGF, which are crucial for hair follicle stimulation and growth.

These bioactive molecules extend the hair's growth phase and encourage the activation of hair follicles, offering a potent solution to combat hair thinning and loss, and promoting denser, healthier hair growth.

RiboHair 1 mL vial

RiboHair 1 mL vial

DR. DANESSA ZINI

Hair surgeon | Aesthetic doctor | Trichologist
Specializes in Dermacell rejuvenation & hair restoration
Operates in Italy, Spain, Dominican Republic & Ecuador
Founder Procapelli Clinic

“RiboHair is a more targeted and simpler procedure with faster results. Does not require blood extraction or handling, which reduces stress and anxiety in patients.”

Dr. Danessa Zini

DR. DANESSA ZINI

CLINICAL STUDIES

Activation of dormant hair follicles and stimulation of hair growth in two weeks. Thickens and stimulates growth of existing hair.

Preprogrammed ribosomal hair injections

Preprogrammed ribosomal hair injections

AFTER 4 APPLICATIONS

  • CASE STUDY #01

    Before

    after

    RiboHair

  • CASE STUDY #02

    Before

    after

    RiboHair

Preprogrammed ribosomal hair injections

Preprogrammed ribosomal hair injections

AFTER 4 APPLICATIONS

  • CASE STUDY #03

    Before

    after

    RiboHair

  • CASE STUDY #04

    Before

    after

    RiboHair

THANK YOU.

THANK YOU.

ALL RIGHTS RESERVED | 2024 RIBODEX LLC